PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"26089353","HIV-1 VACCINES. HIV-1 neutralizing antibodies induced by native-like envelope trimers","Sanders RW, van Gils MJ, Derking R, Sok D, Ketas TJ, Burger JA, Ozorowski G, Cupo A, Simonich C, Goo L, Arendt H, Kim HJ, Lee JH, Pugach P, Williams M, Debnath G, Moldt B, van Breemen MJ, Isik G, Medina-Ramírez M, Back JW, Koff WC, Julien JP, Rakasz EG, Seaman MS, Guttman M, Lee KK, Klasse PJ, LaBranche C, Schief WR, Wilson IA, Overbaugh J, Burton DR, Ward AB, Montefiori DC, Dean H, Moore JP.","Science. 2015 Jul 10;349(6244):aac4223. doi: 10.1126/science.aac4223. Epub 2015 Jun 18.","Sanders RW","Science","2015","2015/06/20","PMC4498988","NIHMS703552","10.1126/science.aac4223"
"31820734","Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics","Durham ND, Agrawal A, Waltari E, Croote D, Zanini F, Fouch M, Davidson E, Smith O, Carabajal E, Pak JE, Doranz BJ, Robinson M, Sanz AM, Albornoz LL, Rosso F, Einav S, Quake SR, McCutcheon KM, Goo L.","Elife. 2019 Dec 10;8:e52384. doi: 10.7554/eLife.52384.","Durham ND","Elife","2019","2019/12/11","PMC6927745","","10.7554/eLife.52384"
"32454405","A (class-)switch in the antibody response may distinguish primary from secondary dengue virus infection","Levoir L, Goo L.","EBioMedicine. 2020 Jun;56:102790. doi: 10.1016/j.ebiom.2020.102790. Epub 2020 May 23.","Levoir L","EBioMedicine","2020","2020/05/27","PMC7248425","","10.1016/j.ebiom.2020.102790"
"24859529","Early development of broadly neutralizing antibodies in HIV-1-infected infants","Goo L, Chohan V, Nduati R, Overbaugh J.","Nat Med. 2014 Jun;20(6):655-8. doi: 10.1038/nm.3565. Epub 2014 May 25.","Goo L","Nat Med","2014","2014/05/27","PMC4060046","NIHMS586217","10.1038/nm.3565"
"22740394","Neutralizing antibody escape during HIV-1 mother-to-child transmission involves conformational masking of distal epitopes in envelope","Goo L, Milligan C, Simonich CA, Nduati R, Overbaugh J.","J Virol. 2012 Sep;86(18):9566-82. doi: 10.1128/JVI.00953-12. Epub 2012 Jun 27.","Goo L","J Virol","2012","2012/06/29","PMC3446598","","10.1128/JVI.00953-12"
"22837204","A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection","Goo L, Jalalian-Lechak Z, Richardson BA, Overbaugh J.","J Virol. 2012 Oct;86(19):10857-61. doi: 10.1128/JVI.01414-12. Epub 2012 Jul 25.","Goo L","J Virol","2012","2012/07/28","PMC3457273","","10.1128/JVI.01414-12"
"25378497","Mutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer","Boyd DF, Peterson D, Haggarty BS, Jordan AP, Hogan MJ, Goo L, Hoxie JA, Overbaugh J.","J Virol. 2015 Jan 15;89(2):894-907. doi: 10.1128/JVI.02680-14. Epub 2014 Nov 5.","Boyd DF","J Virol","2015","2014/11/08","PMC4300673","","10.1128/JVI.02680-14"
"23856624","HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype","Mabuka J, Goo L, Omenda MM, Nduati R, Overbaugh J.","AIDS. 2013 Jun 19;27(10):1535-44. doi: 10.1097/QAD.0b013e32835faba5.","Mabuka J","AIDS","2013","2013/07/17","PMC4080909","NIHMS597001","10.1097/QAD.0b013e32835faba5"
